NIPT (noninvasive prenatal testing) is covered by most insurance plans, but the extent of coverage depends on your insurer, your plan, and whether your pregnancy is considered high-risk. Some plans now cover NIPT for all pregnant people regardless of risk level, while others still restrict coverage to pregnancies that meet specific high-risk criteria. The difference can mean paying nothing out of pocket or facing a bill of $500 to $1,500 or more.
What Most Private Insurers Cover
Nearly all major private insurers cover NIPT when a pregnancy is classified as high risk. Where they differ is in how they define “high risk” and whether they extend coverage to average-risk pregnancies. The American College of Obstetricians and Gynecologists (ACOG) updated its guidance to support offering cell-free DNA screening to all patients regardless of maternal age or baseline risk, and some insurers have followed that lead. Others have not.
UnitedHealthcare recently dropped its prior authorization requirement for NIPT, meaning your provider no longer needs pre-approval before ordering the test. However, the company still ties reimbursement to its own medical necessity criteria. In practice, this means the test can be ordered quickly, but if your pregnancy doesn’t meet UHC’s definition of medical necessity, you could still be responsible for the cost.
Aetna covers NIPT when specific clinical criteria are met, and it explicitly will not pay for the test if you’ve already had another chromosomal screening (such as a quad screen or sequential screening) during the same pregnancy. It also won’t cover a second round of NIPT in the same pregnancy. This is a common policy across insurers: one chromosomal screening per pregnancy, not multiple overlapping tests.
What Qualifies as “High Risk”
If your insurer limits NIPT coverage to high-risk pregnancies, you generally qualify if any of the following apply:
- Maternal age: You will be 35 or older at your expected delivery date.
- Abnormal screening results: A first- or second-trimester blood test or an ultrasound has flagged an increased risk of a chromosomal condition.
- Prior pregnancy history: You’ve had a previous pregnancy affected by trisomy 13, 18, or 21.
- Family history: Either parent carries a chromosomal rearrangement (called a balanced Robertsonian translocation) that raises the chance of trisomy 13 or 21.
- Ultrasound findings: Your provider has identified markers that suggest an increased risk of a chromosomal abnormality.
If none of these apply to you, your insurer may classify your pregnancy as average risk and deny coverage. That said, the trend is moving toward broader coverage. Some plans now approve NIPT for any singleton or twin pregnancy after 10 weeks of gestation, as long as you’ve had pretest genetic counseling and haven’t already completed a different chromosomal screening during the current pregnancy.
Medicaid and State-Based Coverage
Medicaid coverage for NIPT varies dramatically by state and by the managed care organization handling your plan. Some Medicaid managed care plans, like those administered by Centene Corporation, cover NIPT for all singleton and twin pregnancies. The requirements are straightforward: you need pretest counseling, you must be at least 10 weeks along, and you can’t have already had another chromosomal screening in the same pregnancy.
Other Medicaid plans are more restrictive. Molina Healthcare, for example, covers NIPT only for high-risk pregnancies and requires that the lab performing the test be an in-network provider. If you’re on Medicaid, your best move is to call the number on your insurance card and ask specifically about cell-free DNA screening. The coverage rules for your state and plan may be different from what you find online about Medicaid in general.
Prior Authorization and How to Avoid Surprise Bills
Some insurers require prior authorization before NIPT is performed. This means your provider’s office submits documentation (your age, screening history, risk factors) and waits for approval before sending your blood sample to the lab. If the test is done without prior authorization on a plan that requires it, you risk having the claim denied entirely.
Even when prior authorization isn’t required, as with UnitedHealthcare’s recent policy change, coverage still hinges on meeting the plan’s medical necessity definition. Dropping the prior auth requirement makes the process faster, but it doesn’t guarantee the test is covered. You can still receive a bill after the fact if your claim is reviewed and found not to meet the criteria.
To protect yourself, take these steps before your blood is drawn:
- Call your insurer directly. Ask whether NIPT (cell-free DNA screening) is covered under your plan and whether prior authorization is needed. Get a reference number for the call.
- Ask about the lab. NIPT is processed by specialized labs, and not all of them are in-network with every plan. An out-of-network lab can result in a much higher bill. Your provider’s office can usually tell you which lab they use, and you can verify network status with your insurer.
- Clarify which panel is covered. Standard NIPT screens for trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. Some labs offer expanded panels that screen for additional conditions like microdeletions or sex chromosome differences. The expanded panels use different billing codes and are more likely to be denied or excluded from coverage.
Standard vs. Expanded Panels
This distinction matters more than most people realize. The standard NIPT panel screens for the three most common trisomies (chromosomes 13, 18, and 21) and can optionally report fetal sex. This is the version most insurers cover. It uses specific billing codes (CPT 81420 and 81507 are the most common) that insurers recognize and have policies for.
Expanded panels add screening for rarer conditions, including microdeletion syndromes and other chromosomal abnormalities. These panels are billed under separate codes, including one for microdeletion analysis (81422) and sometimes an “unlisted procedure” code (81479). Claims filed under unlisted procedure codes are more likely to be denied or to require additional documentation, because the insurer has no pre-set policy for that specific code. If your provider recommends an expanded panel, ask whether the additional screens are covered before agreeing to them.
Twin Pregnancies
Coverage for NIPT in twin pregnancies is less predictable. Some insurers, like plans under Centene, explicitly include twin gestations in their coverage criteria. Others limit coverage to singleton pregnancies or require high-risk criteria to be met regardless of the number of fetuses. Twin pregnancies also have a dedicated billing code (0060U) for zygosity testing, which determines whether twins are identical or fraternal. This code may or may not be covered separately. If you’re carrying twins, verify coverage specifically for a multifetal pregnancy rather than assuming your plan’s general NIPT policy applies.
What to Do if You’re Denied or Uninsured
If your insurance denies coverage, you have a few options. First, ask your provider to submit an appeal with supporting clinical documentation. If you have any risk factor, even a borderline one, a letter from your OB or midwife explaining the medical rationale can sometimes reverse a denial.
Many of the labs that process NIPT offer their own financial assistance or self-pay pricing programs. These programs often bring the out-of-pocket cost down to $99 to $350, which is dramatically lower than the list price labs bill to insurance (which can exceed $1,000). If you’re paying out of pocket, ask the lab directly about self-pay rates before the test is ordered. In many cases, the self-pay price is actually lower than what you’d owe after insurance processes the claim and applies it to an unmet deductible.
If you’re uninsured, these lab-sponsored pricing programs are typically your most affordable path. Some are income-based, while others offer a flat self-pay rate to anyone without coverage. Your provider’s office can usually point you to the program affiliated with the lab they use.